Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics — United States, September 1, 2022–September 30, 2023

MMWR Morbidity and Mortality Weekly Report, Journal Year: 2024, Volume and Issue: 73(13), P. 286 - 290

Published: April 4, 2024

The Federal Retail Pharmacy Program (FRPP) facilitated integration of pharmacies as partners in national efforts to scale up vaccination capacity during the COVID-19 pandemic emergency response.To evaluate FRPP's contribution across various sociodemographic groups, data on bivalent mRNA vaccine doses administered September 1, 2022-September 30, 2023, were evaluated from two sources: 1) FRPP reported directly CDC and 2) jurisdictional immunization information systems all 50 states, District Columbia, U.S. territories, freely associated states.Among 59.8 million United States this period, 40.5 (67.7%) by partners.The proportion ranged 5.9% among children aged 6 months-4 years 70.6% adults 18-49 years.Among some racial ethnic minority groups (e.g., Hispanic or Latino, non-Hispanic Black African American, Native Hawaiian other Pacific Islander, Asian persons), ≥45% partners.Further, urban rural areas, 81.6% 60.0% doses, respectively.The partnership approximately thirds provided access for persons a wide range demonstrating that program could serve model address services needs routine vaccines provide health public emergencies.

Language: Английский

A survey of state and local practices encouraging pediatric COVID-19 vaccination of children ages 6 months through 11 years

Vaccine, Journal Year: 2024, Volume and Issue: 42, P. 125837 - 125837

Published: April 9, 2024

This report highlights state and local practices for optimizing the pediatric COVID-19 vaccination program children ages 6 months through 11 years.

Language: Английский